Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Abitare In Spa | BIT:ABT | Italy | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.04 | 0.95% | 4.27 | 4.29 | 4.33 | 4.38 | 4.27 | 4.38 | 2,296 | 09:10:00 |
From Nov 2019 to Nov 2024
Belgian chemical and pharmaceutical company Solvay SA (SOLB.BT) is unlikely to announce any new acquisition before closing the sale of its pharma business to Abbott Laboratories (ABT), its chief executive said Monday.
"Don't expect anything before the closing," Christian Jourquin said during a press conference where he presented the sale of the pharma business, announced earlier Monday. The company won't spend money it doesn't have, he said.
Brussels-based Solvay expects to close the sale by the first quarter of 2010, and won't change its capital expenditure plans for next year, Jourquin said.
-By Alessandro Torello, Dow Jones Newswires; +32 2 741 14 88; alessandro.torello@dowjones.com
1 Year Abitare In Chart |
1 Month Abitare In Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
